Active ingredientLanicemineCat. No. P-L012-001CAS 153322-05-5Family · Pharmaceutical analytical standards
Lanicemine
An NMDA glutamate receptor antagonist studied for severe and treatment-resistant depression; its development was stopped in 2013, without reaching approval. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is a 'low-trapping' NMDA antagonist: in clinical trials it showed rapid antidepressant effects similar to ketamine's, but with few or no psychotomimetic effects.
Go to the active ingredient →Active ingredientLanicemineCat. No. P-L012-001CAS 153322-05-5
Isotopically labelledent-Lanicemine-d5Cat. No. P-L012-002
Isotopically labelledLanicemine-d5 DiHClCat. No. P-L012-003
Isotopically labelledLanicemine-d6 2HClCat. No. P-L012-004
Isotopically labelledrac-Lanicemine-d5 DiHClCat. No. P-L012-005
Active ingredientLanicemine 2HClCat. No. P-L012-006CAS 153322-06-6
Impurityrac-Lanicemine DiHClCat. No. P-L012-007CAS 153200-70-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.